Are You at Risk for
Getting Ashkenazi Genetic Diseases?
Did you know that Ashkenazi Jews are prone to genetic mutations that may increase the risk of developing certain diseases?
Most notable are mutations of the BRCA1 and BRCA2 genes which increase the risk of developing breast & ovarian cancer at an early age. They also increase the risk of a man developing prostate cancer, both at an early age and in a more aggressive form.
• Increase your awareness of diseases that are caused by genetic abnormalities among Ashkenazi Jews
• Learn about screening tests that can identify them
• Become familiar with interventions to reduce the risk of getting such diseases.
Thursday, Oct 15th, 2020
NOTE TIME CHANGE > SPEAKERS: 4:00–5:00PM PST
BREAKOUT SESSIONS:5.00-6.00 PM PST
4 Breakout Session Options:
breast session, prostate session, genetic counselor session & carrier screening.
Available to all registered guests to have all your questions answered by experts in their fields
Zoom Meeting from the comfort of your own home
Registration necessary beforehand
(Registration required beforehand)
- Our Symposium is supported by generous donations from our sponsors:
Myriad is an established leader in the field of hereditary cancer genetic testing with nearly 30 years of experience and approximately 5 million patients tested. We are committed to providing patients with affordable and accurate information that they can rely upon when decisions matter most.
Invitae is a leader in advanced medical genetics. Our company was founded with a singular mission: to make genetic information affordable and accessible to everyone who can benefit from it. The Invitae team includes pioneers in genetics, medicine, technology, and genetic counseling, and is trusted by experts to provide the most comprehensive, reliable genetic screening and support available. Invitae addresses genetic questions through all stages of life and all areas of medicine. Improving the quality of healthcare by making genetic information affordable and accessible for everyone.
Sharsheret, Hebrew for chain, is the only national organization supporting Jewish women and families, of all backgrounds, facing breast and ovarian cancer—those who are diagnosed and those at high risk. They are accredited by the Better Business Bureau and have earned a 4-star rating from Charity Navigator for sound fiscal management and commitment to accountability and transparency.
JScreen is a national non-profit public health initiative dedicated to preventing Jewish genetic diseases. Headquartered in Atlanta at Emory University School of Medicine, JScreen offers at-home carrier testing for over 200 genetic diseases that could impact a couple’s future children, as well as follow up genetic counseling services. JScreen is also launching a cancer genetic testing program in October 2020.